Compare LYFT Inc (LYFT) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LYFT Inc vs Oruka Therapeutics Inc. Common Stock — how do they compare? LYFT Inc trades at $16.42 (market cap $6.24B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.08B). The key difference: LYFT Inc is the larger of the two by market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, LYFT Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold LYFT Inc for 48 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| LYFT | ORKA | |
|---|---|---|
Market Cap | $6.24B | $5.08B |
Volume | 12,746,078 | 685,276 |
Sector | Technology | Health |
52-Week High | $24.57 | $113.08 |
52-Week Low | $12.65 | $26.19 |
Typical Hold Time | 48 Days | 0 Days |
Enterprise Value | $5.71B | $4.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Lyft trades at $16.38, up 1.68% with a bullish technical signal. The company shows strong profitability with 45.52% gross margins and 42.32% net income margin, though recent earnings missed expectations. Positive developments include European expansion and a major partnership with Sphere Entertainment. Cash flow improved significantly to $891M in 2025 from negative levels in prior years.
Lyft presents a mixed outlook with strong fundamentals but execution risks. The stock trades below analyst consensus target of $18.07, offering potential upside. Key risks include regulatory challenges from the $272.5M driver classification settlement and competitive pressures. Institutional sentiment leans cautious with 58% hold ratings despite improving financial metrics.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About LYFT Inc
Lyft is the second-largest ride-sharing service provider in the U.S., connecting riders and drivers over the Lyft app. Lyft recently entered the Canadian market in an effort to expand its market outside the U.S. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.
Read more on LYFT →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
